Filed Pursuant to Rule 433 of the Securities
Act of 1933
Issuer Free Writing
Prospectus dated July 15, 2015
Registration No. 333-203238
Up to 3,125,000 Units
Consisting of One Share of Common Stock and
One Warrant to Purchase One-half Share of Common Stock
This free writing prospectus relates to the
initial public offering of common stock and warrants of Innovation Economy Corporation, which does business under the name “ieCrowd”.
It should be read together with ieCrowd’s final prospectus dated July 10, 2015 relating to the offering, which has been filed
by ieCrowd with the Securities and Exchange Commission (the SEC) and which may be accessed through the following web link:
http://www.sec.gov/Archives/edgar/data/1563004/000121390015005095/f424b3071015_innovation.htm
It should also be read together with any later-dated prospectus
relating to the offering and the other documents filed by ieCrowd with the SEC. As stated in ieCrowd’s prospectus, investing
in ieCrowd securities involves a high degree of risk. ieCrowd is at an early stage of its development and its securities may only
be appropriate for long-term investment. ieCrowd’s independent registered public accounting firm has issued an audit opinion
that includes a statement expressing substantial doubt as to ieCrowd’s ability to continue as a going concern. You should
purchase ieCrowd securities only if you can afford to lose your entire investment.
Innovation Economy Corporation has filed a final prospectus with
the Securities and Exchange Commission, or the SEC, for the offering to which this communication relates. Before you invest, you
should read the final prospectus and other documents Innovation Economy Corporation has filed with the SEC for more complete information
about Innovation Economy Corporation and this offering. You may get these documents for free by visiting EDGAR on the SEC web site
at www.sec.gov. Alternatively, a copy of the prospectus may be obtained from TriPoint Global Equities, LLC if you
request it by calling, toll-free, 1-800-304-6994.
Market
Data, Product Timing & Addressable Market Info Sheet
KITE
KiteTM products
are being designed to block mosquitoes from detecting and biting humans, with a goal of reducing human suffering from malaria,
dengue fever, West Nile virus, and other mosquito-borne diseases.
Market
Size
| · | Half
the world’s population at risk for malaria, estimated 207 million cases of malaria
worldwide in 20121, malaria kills up to 600k people each year2,
economic impact to Africa estimated $12 billion per year3 |
| · | One-third
world’s population at risk for dengue fever, estimated 400 million infections occur
globally per year4, total annual cost of dengue in the Americas $2.1 billion5 |
| · | Global
annual mosquito-repellent coil sales estimated at $2.25B (at $0.05/coil – range
is $0.02-$0.65)6 |
| · | U.S.
insect repellent market valued at $527M7 |
| · | $450M
U.S. bed bug control revenue earned by pest management professionals (PMPs) in 20138,
up 11% from prior year, in survey of PMPs in 2013, 99.6% treated bed bugs in previous
12 month period9 |
Inflection
Points (Projected) Regulated
| · | Regulatory
– U.S. EPA submissions early as 1H 2016 and approval beginning early as 2018 |
| · | Regulatory
– international submissions to follow |
| · | Approval
and manufacture ready – early as 2018 |
| · | Licensing
– agreements early as 2016 |
Unregulated
| · | Manufacture
ready – early as 1H 2016 |
| · | Licensing
– agreements early as 2016 |
NUUMA
NuumaTM
is a tiny nano-based sensor being designed to detect airborne gases at the parts per billion (ppb) level, envisioned as a “digital
nose” for mobile devices, with potential consumer and professional uses ranging from testing indoor/outdoor air quality
to early disease detection to homeland security.
Market
Size
| · | Estimated
7 million premature deaths due to air pollution (indoor and outdoor) worldwide 201210 |
| · | Global
gas sensor market is estimated to increase from $1.9 billion in 2014 to $2.32 billion
by 2018 with a CAGR of 5.56%11 |
| · | Global
wearable technology market $750 million in 2012, expected to reach $5.8 billion in 2018,
at a CAGR of 40.8% from 2012 to 201812 |
| · | Global,
annual wearables market expected to reach $11.61B by 202013 |
| · | U.S.
market for indoor air quality equipment was valued at over $7.7 billion in 2013 and is
projected to grow to $11.4 billion by 2019, a five-year CAGR of 7%14 |
| · | $563M
Chinese sales of air purifiers in 201315 |
Inflection
Points (Projected)
| · | Regulatory
– Not applicable for sensor chips integrated into 3rd party products |
| · | Regulatory
– For Nuuma branded products, industry certifications early as 2H 2016 |
| · | Approval
and manufacture ready – early as 2H 2016 |
| · | Licensing–
agreements early as 1H 2016 |
SMART OXYGEN
Smart Oxygen SolutionsTM
is developing an intelligent breathing device for COPD patients and others who need supplemental oxygen, with a goal of
providing a more accurate dose of oxygen to patients based on their levels of activity.
Market
Size
| · | In
U.S. 14.8 million diagnosed patients and estimated 12 million un-diagnosed16 |
| · | Total
cost of COPD and other smoking related diseases in China in 2000 over $5 Billion17 |
| · | COPD
2nd leading cause of death in China18, 3rd leading cause
of death U.S.19 |
| · | The
global oxygen therapy devices market was valued at $1.90 billion in 2013 and is expected
to grow at a CAGR of 5.7% from 2014 to 2020, with estimated value of $2.80 billion in
202020 |
Inflection
Points (Projected)
| · | Regulatory
– expect FDA 510(k) submission early as Q4 2015 |
| · | Manufacture
ready – early as 1H 2016 |
| · | Licensing
– agreements early as 2016 |
MIGRAINE
AND HEAD PAIN
ieCrowd is developing
a non-pharmaceutical and non-invasive technology that has the potential to treat pain from migraines and headaches and other
head pain. The technology is designed to stimulate the sensory fibers of a nerve in order to mask pain perception.
Market
Size
| · | In
the U.S., 1 in 4 households has 1 person suffering from migraines21, more
than 37 million people suffer from migraines22 |
| · | Migraine
therapies market to increase from $3.3B in 2011 to $5.8B in 202123 |
Inflection
Points (Projected)
| · | Regulatory
– 6-month human trial early as 1H 2016 |
| · | Approval
– no timeline provided at this time |
| · | Licensing
– no timeline provided at this time |
SLEEP
DISORDER
ieCrowd
is developing non-pharmaceutical, non-invasive potential therapeutic treatments for sleep disorders. The technology, developed
at UCLA, takes advantage of the fact that signals from the limbs can be interpreted by the brain as movement and can alter breathing
rates.
Market
Size
| · | 42
million people in the U.S. have sleep-disordered breathing, including sleep apnea24.
Sleep apnea can increase the risk of heart attack, stroke, obesity, high blood pressure
and diabetes25 |
| · | Global
sleep apnea device market valued at $7.9B in 2011, expected to reach $19.7B by 2017 (diagnostics
and therapeutics). North America largest market, followed by Europe and Asia26 |
| · | Estimated
100 million people worldwide could have obstructive sleep apnea of which 80% remain undiagnosed27 |
Inflection
Points (Projected)
| · | Regulatory
– 6-month human trial early as 1H 2016 |
| · | Approval
– no timeline provided at this time |
| · | Licensing
– no timeline provided at this time |
CURRENT
ADDRESSABLE MARKET ESTIMATE
ieCrowd
estimates that its 5 innovations in development have an addressable market of approximately $13 billion based on multiple public
sources and management estimates:
| · | $3.2B
Kite (coils $2.25B, repellents $527M, bed bugs $450M) |
| · | $2.96B
Nuuma (gas sensors $1.9B, wearables 2013 estimate $1.06B) |
| · | $190M
Smart Oxygen (10% of $1.9B global oxygen therapy device market) |
| · | $3.8B
Migraine and Head Pain (migraine therapies 2013 estimate $3.8B) |
| · | $3.2B
Sleep Disorder (30% of 2013 estimate of $10.7B diagnostics and therapeutics sleep apnea
device market) |
This is not an offer
to sell, or a solicitation of an offer to buy, any securities. Securities may not be offered or sold in the United States absent
registration or an exemption from registration. ieCrowd has filed a registration statement (including a prospectus) with the SEC
for the initial public offering of its securities. The prospectus contains detailed information about the company and management,
as well as financial statements. You can get the prospectus, and other documents filed with the SEC by ieCrowd, by visiting EDGAR
at SEC.gov or by calling, toll-free, 800-304-6994.
Investing
in our company involves a high degree of risk. We are at an early stage of our development and our securities may only be appropriate
for long-term investment. Our independent registered public accounting firm has issued an audit opinion that includes a statement
expressing substantial doubt as to our ability to continue as a going concern. You should purchase our securities only ifyou can
afford to lose your entire investment.
Certain of
the statements in this document constitute forward-looking statements, including statements regarding our future results, strategies,
plans and prospects. All of our forward-looking statements involve significant risks and uncertainties. There can be no assurance
that any of them will prove to be accurate, and our actual future results, strategies, plans and prospects may differ materially
and adversely from those stated or suggested in our forward-looking statements. Please see the “Risk Factors” section
and the other disclosure in our prospectus.
1
http://www.cdc.gov/malaria/malaria_worldwide/impact.html
2
http://www.cdc.gov/malaria/malaria_worldwide/impact.html
3
http://www.ajtmh.org/content/64/1_suppl/85.full.pdf+html
4
http://www.cdc.gov/dengue/
5
http://www.denguematters.info/content/issue-2-economic-burden-dengue
6
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859469/
7
http://www.sec.gov/Archives/edgar/data/1487730/000148773014000066/spb-20140930x10k.htm
8
http://www.pctonline.com/SPC-market-research.aspx
9
http://www.pestworld.org/all-things-bed-bugs/history-of-bed-bugs/bed-bug-facts-statistics/
10
http://www.who.int/mediacentre/news/releases/2014/air-pollution/en/
11
http://www.mordorintelligence.com/industry-reports/global-gas-sensors-market-industry
12
http://www.prweb.com/releases/2014/01/prweb11478994.htm
13
http://www.marketsandmarkets.com/PressReleases/wearable-electronics.asp
14
http://www.bccresearch.com/market-research/environment/indoor-air-quality-market-report-env003e.html
15
http://daxueconsulting.com/air-purifiers-market-in-china/
16
http://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook.pdf
17
http://www.atsjournals.org/doi/pdf/10.1164/rccm.200706-927ED
18
http://www.atsjournals.org/doi/full/10.1164/rccm.200706-927ED#.VXO6ds9Viko
19
http://www.businesswire.com/news/home/20101209006673/en/COPD-Ranked-Leading-Death-U.S.-CDC-Reports
20
http://www.releasewire.com/press-releases/oxygen-therapy-devices-market/release-587503.htm
21
http://www.migraineresearchfoundation.org/fact-sheet.html
22
http://www.headaches.org/2007/10/25/migraine/
23
http://decisionresources.com/News-and-Events/Press-Releases/Migraine-Drug-Market-111512
24
http://www.nhlbi.nih.gov/about/org/ncsdr/
25
http://www.webmd.com/sleep-disorders/sleep-apnea/sleep-apnea-conditions
26
http://www.marketsandmarkets.com/PressReleases/sleep-apnea-devices.asp
27
http://www.marketsandmarkets.com/PressReleases/sleep-apnea-devices.asp
3
INNOVATION ECONOMY CORP (NASDAQ:MYIE)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
INNOVATION ECONOMY CORP (NASDAQ:MYIE)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025
